Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- 2019-nCoV Vaccine mRNA-1273 2
- 2019-nCoV Vaccine MRNA-1273 1
- Adolescent 9
- Adult 10
- Africa South of the Sahara 1
- Aged 6
- Aged, 80 And Over 1
- Aged, 80 and over 1
- Age Distribution 1
- Antibodies, Neutralizing 1
- Antibodies, Viral 1
- Antiviral Agents 1
- Bacterial Infections 1
- BNT162 Vaccine 3
- Case-Control Studies 1
- Child 10
- Child, Preschool 10
- Coinfection 3
- CoronaVirus Infections 1
- Coronavirus Infections 1
- Cost-Benefit Analysis 2
- Cost of Illness 1
- COVID-19 10
- Covid-19 1
- COVID-19 Vaccines 6
- Cross-Sectional Studies 1
- Data Collection 1
- Diagnostic Tests, Routine/methods 1
- Diagnostic Tests, Routine/standards 1
- Diarrhea 1
- Disease burden 1
- Disease Outbreaks 1
- EnteroVirus D, Human 1
- EnteroVirus Infections 1
- Female 11
- Full Report 1
- Guidelines as Topic 1
- Health Behavior 1
- Healthcare utilization 1
- Health Priorities 1
- Health Resources 1
- Health Surveys 1
- History, 21St Century 1
- History, 21st Century 1
- HIV 1
- HIV Infections 6
- Hiv Infections 1
- Hospitalization 10
- Hospital Mortality 3
- Humans 24
- Immunization 1
- Immunization, Secondary 1
- Immunization Programs 1
- Immunocompetence 1
- Immunocompromised Host 1
- Incidence 3
- Infant 14
- Infant, Newborn 6
- Influenza 2
- influenza 2
- Influenza, Human 8
- Influenza, Human/epidemiology 1
- Influenza, Human/prevention & control 1
- Influenza A virus 1
- Influenza Vaccines 3
- Inpatients 2
- Internship and Residency 1
- Logistic Models 1
- Malaria/diagnosis 1
- Male 10
- Mali 1
- Mass Screening 1
- Meningitis 1
- Microscopy 1
- Middle Aged 8
- Monte Carlo Method 1
- Odds Ratio 1
- Original Article 2
- Original Articles 1
- Orthomyxoviridae 1
- Outpatients 2
- Oxygen 1
- Population Surveillance 5
- Pregnancy 2
- Prevalence 2
- Respiration, Artificial 2
- Respiratory Syncytial Virus, Human 2
- Respiratory Syncytial Virus Infections 4
- Respiratory Tract Infections 3
- Risk Factors 2
- RNA, Messenger 2
- SARS-CoV-2 9
- Seroepidemiologic Studies 2
- Severity of Illness Index 2
- South Africa 6
- United States 2
- Vaccination 6
- Vaccine Efficacy 4
- Vaccines, Combined 2
- Young Adult 5
Personal Author
Corporate Author
- Atlanta Veterans Affairs Medical Center, Atlanta, Georgia 1
- Baylor Scott & White Health. 1
- Baystate Medical Center, Springfield, Massachusetts 1
- California Emerging Infections Program 1
- Career Epidemiology Field Officer Program 1
- CDC COVID-19 Emergency Response Team 1
- CDC COVID-19 Emergency Response Team. 1
- Centers for Disease Control and Prevention (U.S.) 1
- Colorado Dept. of Public Health and Environment 1
- COVID-NET Surveillance Team 2
- Emory University School of Medicine 1
- Epidemic Intelligence Service 1
- for the PHIRST-C Group1 2
- General Dynamics Information Technology 1
- Georgia Emerging Infections Program 1
- Hennepin County Medical Center. 1
- Intermountain Medical Center. 1
- Investigating Respiratory Viruses in the Acutely Ill (IVY) Network 1
- Iowa Dept. of Public Health 1
- IVY Network 4
- IVY Network. 1
- Johns Hopkins Hospital. 1
- Maryland Dept. of Health 1
- Michigan Dept. of Health and Human Services 1
- Minnesota Dept. of Health 1
- Montefiore Medical Center and Albert Einstein College of Medicine. 1
- New Mexico Dept. of Health 1
- New York State Dept. of Health 1
- Ohio Dept. of Health 1
- Oregon Health Authority Public Health Div. 1
- PHIRST-C group 1
- Salt Lake County, Utah Health Dept. 1
- Texas A&M University College of Medicine. 1
- University of Colorado School of Medicine, Aurora, Colorado 1
- University of Iowa. 1
- University of Michigan School of Public Health. 1
- University of Rochester School of Medicine and Dentistry 1
- University of Utah. 1
- University of Washington School of Medicine. 1
- Vanderbilt University Medical Center 1
- Vanderbilt University Medical Center, Nashville, Tennessee. 1
- Wake Forest University Baptist Medical Center. 1
- Yale University School of Public Health Connecticut Emerging Infections Program 1
Place as Subject
- Africa, Western 1
- California 2
- Colorado 2
- Connecticut 1
- Florida 1
- Georgia 2
- Ghana 1
- Guinea 1
- Iowa 2
- Kenya 2
- Liberia 1
- Maryland 2
- Massachusetts 1
- Michigan 2
- Minnesota 2
- Missouri 1
- New Mexico 1
- New York 2
- North Carolina 1
- Ohio 2
- Oregon 2
- Sierra Leone 1
- South Africa 8
- Tanzania 1
- Tennessee 2
- Texas 1
- U.S. 2
- United States 2
- Utah 2
- Washington 1
Resource Type General
Resource Type Specific
Keywords
- Africa 1
- Africa South of the Sahara 1
- Attributable fraction 1
- Biological Variation, Population 1
- burden 1
- Burden of disease 1
- Chlorination 1
- Comorbidity 1
- Cost-Benefit Analysis 1
- cost effectiveness 1
- Cost of Illness 1
- COVID-19 1
- death 1
- Disease Management 1
- Female 1
- HIV exposure 1
- HIV infection 1
- Hospitalization 1
- hospitalization 1
- Household water treatment 1
- human 1
- human immunodeficiency virus 1
- Humans 1
- incidence 1
- infant 1
- infants 1
- influenza 3
- Influenza 2
- Influenza, Human 1
- Male 1
- maternal 1
- Models, Theoretical 1
- mortality 2
- Mortality 1
- Practice Patterns, Physicians' 1
- pregnant 1
- Prognosis 1
- Public Health Surveillance 1
- rates 1
- Respiratory syncytial virus 1
- respiratory syncytial virus 1
- Respiratory Tract Diseases 1
- Safe water storage 1
- SARS-CoV-2 1
- severe disease 1
- South Africa 3
- Symptom Assessment 1
- vaccine 1
- Vaccine policy 1
Select all docs (Max 200)
1 -
20 of 31 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- 2019-nCoV Vaccine mRNA-1273 (2)
- 2019-nCoV Vaccine MRNA-1273 (1)
- Adolescent (9)
- Adult (10)
- Africa South of the Sahara (1)
- Aged (6)
- Aged, 80 And Over (1)
- Aged, 80 and over (1)
- Age Distribution (1)
- Antibodies, Neutralizing (1)
- Antibodies, Viral (1)
- Antiviral Agents (1)
- Bacterial Infections (1)
- BNT162 Vaccine (3)
- Case-Control Studies (1)
- Child (10)
- Child, Preschool (10)
- Coinfection (3)
- CoronaVirus Infections (1)
- Coronavirus Infections (1)
- Cost-Benefit Analysis (2)
- Cost of Illness (1)
- COVID-19 (10)
- Covid-19 (1)
- COVID-19 Vaccines (6)
- Cross-Sectional Studies (1)
- Data Collection (1)
- Diagnostic Tests, Routine/methods (1)
- Diagnostic Tests, Routine/standards (1)
- Diarrhea (1)
- Disease burden (1)
- Disease Outbreaks (1)
- EnteroVirus D, Human (1)
- EnteroVirus Infections (1)
- Female (11)
- Full Report (1)
- Guidelines as Topic (1)
- Health Behavior (1)
- Healthcare utilization (1)
- Health Priorities (1)
- Health Resources (1)
- Health Surveys (1)
- History, 21St Century (1)
- History, 21st Century (1)
- HIV (1)
- HIV Infections (6)
- Hiv Infections (1)
- Hospitalization (10)
- Hospital Mortality (3)
- Humans (24)
- Immunization (1)
- Immunization, Secondary (1)
- Immunization Programs (1)
- Immunocompetence (1)
- Immunocompromised Host (1)
- Incidence (3)
- Infant (14)
- Infant, Newborn (6)
- Influenza (2)
- influenza (2)
- Influenza, Human (8)
- Influenza, Human/epidemiology (1)
- Influenza, Human/prevention & control (1)
- Influenza A virus (1)
- Influenza Vaccines (3)
- Inpatients (2)
- Internship and Residency (1)
- Logistic Models (1)
- Malaria/diagnosis (1)
- Male (10)
- Mali (1)
- Mass Screening (1)
- Meningitis (1)
- Microscopy (1)
- Middle Aged (8)
- Monte Carlo Method (1)
- Odds Ratio (1)
- Original Article (2)
- Original Articles (1)
- Orthomyxoviridae (1)
- Outpatients (2)
- Oxygen (1)
- Population Surveillance (5)
- Pregnancy (2)
- Prevalence (2)
- Respiration, Artificial (2)
- Respiratory Syncytial Virus, Human (2)
- Respiratory Syncytial Virus Infections (4)
- Respiratory Tract Infections (3)
- Risk Factors (2)
- RNA, Messenger (2)
- SARS-CoV-2 (9)
- Seroepidemiologic Studies (2)
- Severity of Illness Index (2)
- South Africa (6)
- United States (2)
- Vaccination (6)
- Vaccine Efficacy (4)
- Vaccines, Combined (2)
- Young Adult (5)
- Atlanta Veterans Affairs Medical Center, Atlanta, Georgia (1)
- Baylor Scott & White Health. (1)
- Baystate Medical Center, Springfield, Massachusetts (1)
- California Emerging Infections Program (1)
- Career Epidemiology Field Officer Program (1)
- CDC COVID-19 Emergency Response Team (1)
- CDC COVID-19 Emergency Response Team. (1)
- Centers for Disease Control and Prevention (U.S.) (1)
- Colorado Dept. of Public Health and Environment (1)
- COVID-NET Surveillance Team (2)
- Emory University School of Medicine (1)
- Epidemic Intelligence Service (1)
- for the PHIRST-C Group1 (2)
- General Dynamics Information Technology (1)
- Georgia Emerging Infections Program (1)
- Hennepin County Medical Center. (1)
- Intermountain Medical Center. (1)
- Investigating Respiratory Viruses in the Acutely Ill (IVY) Network (1)
- Iowa Dept. of Public Health (1)
- IVY Network (4)
- IVY Network. (1)
- Johns Hopkins Hospital. (1)
- Maryland Dept. of Health (1)
- Michigan Dept. of Health and Human Services (1)
- Minnesota Dept. of Health (1)
- Montefiore Medical Center and Albert Einstein College of Medicine. (1)
- New Mexico Dept. of Health (1)
- New York State Dept. of Health (1)
- Ohio Dept. of Health (1)
- Oregon Health Authority Public Health Div. (1)
- PHIRST-C group (1)
- Salt Lake County, Utah Health Dept. (1)
- Texas A&M University College of Medicine. (1)
- University of Colorado School of Medicine, Aurora, Colorado (1)
- University of Iowa. (1)
- University of Michigan School of Public Health. (1)
- University of Rochester School of Medicine and Dentistry (1)
- University of Utah. (1)
- University of Washington School of Medicine. (1)
- Vanderbilt University Medical Center (1)
- Vanderbilt University Medical Center, Nashville, Tennessee. (1)
- Wake Forest University Baptist Medical Center. (1)
- Yale University School of Public Health Connecticut Emerging Infections Program (1)
- Africa, Western (1)
- California (2)
- Colorado (2)
- Connecticut (1)
- Florida (1)
- Georgia (2)
- Ghana (1)
- Guinea (1)
- Iowa (2)
- Kenya (2)
- Liberia (1)
- Maryland (2)
- Massachusetts (1)
- Michigan (2)
- Minnesota (2)
- Missouri (1)
- New Mexico (1)
- New York (2)
- North Carolina (1)
- Ohio (2)
- Oregon (2)
- Sierra Leone (1)
- South Africa (8)
- Tanzania (1)
- Tennessee (2)
- Texas (1)
- U.S. (2)
- United States (2)
- Utah (2)
- Washington (1)
- Africa (1)
- Africa South of the Sahara (1)
- Attributable fraction (1)
- Biological Variation, Population (1)
- burden (1)
- Burden of disease (1)
- Chlorination (1)
- Comorbidity (1)
- Cost-Benefit Analysis (1)
- cost effectiveness (1)
- Cost of Illness (1)
- COVID-19 (1)
- death (1)
- Disease Management (1)
- Female (1)
- HIV exposure (1)
- HIV infection (1)
- Hospitalization (1)
- hospitalization (1)
- Household water treatment (1)
- human (1)
- human immunodeficiency virus (1)
- Humans (1)
- incidence (1)
- infant (1)
- infants (1)
- influenza (3)
- Influenza (2)
- Influenza, Human (1)
- Male (1)
- maternal (1)
- Models, Theoretical (1)
- mortality (2)
- Mortality (1)
- Practice Patterns, Physicians' (1)
- pregnant (1)
- Prognosis (1)
- Public Health Surveillance (1)
- rates (1)
- Respiratory syncytial virus (1)
- respiratory syncytial virus (1)
- Respiratory Tract Diseases (1)
- Safe water storage (1)
- SARS-CoV-2 (1)
- severe disease (1)
- South Africa (3)
- Symptom Assessment (1)
- vaccine (1)
- Vaccine policy (1)
- :Tempia, Stefano ;Moyes, JocelynJune 11 2019 | Influenza Other Respir Viruses. 13(5):484-495:BackgroundEconomic burden estimates are essential to guide policy‐making for influenza vaccination, especially in resource‐limited settings.Method...
- :Masanja, Irene M. ;McMorrow, Meredith L.Feb 19 2015 | Malar J. 14.:BackgroundThe World Health Organization (WHO) recommends parasitologic confirmation of suspected malaria cases before treatment. Due to the limited av...
- :Wong, Karen K. ;Cohen, Adam L.Jul 25 2018 | BMC Infect Dis. 18.:BackgroundAsking people how they would seek healthcare in a hypothetical situation can be an efficient way to estimate healthcare utilization, but it ...
- :Tempia, Stefano ;Walaza, SibongileFeb 01 2018 | Influenza Other Respir Viruses. 12(3):360-373.:BackgroundThe attributable fraction of influenza virus detection to illness (INF‐AF) and the duration of symptoms as a surveillance inclusion criter...
- :Kleynhans, Jackie ;Tempia, Stefano12 2021 | Emerg Infect Dis. 2021; 27(12):3020-3029:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections may be underestimated because of limited access to testing. We measured SARS-C...
- :Tempia, Stefano ;Walaza, Sibongile8 30 2019 | Clin Infect Dis. 69(6):1036-1048:Background.Burden estimates of medically and nonmedically attended influenza-associated illness across syndromes and levels of severity are lacking.Me...
- :Ntiri, Michael Preko ;Duque, JazminDec 13 2016 | BMC Infect Dis. 16.:BackgroundInfluenza vaccination is recommended by the World Health Organization for high risk groups, yet few data exist on influenza disease burden i...
- :Tempia, Stefano ;Walaza, SibongileJul 2017 | Emerg Infect Dis. 23(7):1124-1132.:The attributable fraction (AF) of influenza virus detection to illness has not been described for patients in different age groups or with different H...
- :Wei, Stanley C. ;Vanden Eng, Jodi L.3 2012 | J Infect Dis. 205(Suppl 1):S103-S111:BackgroundThe Expanded Program on Immunization Contact Method (EPI-CM) is a proposed monitoring and program management tool for developing countries. ...
- :Tempia, Stefano ;Walaza, SibongileMay 07 2020 | Vaccine. 38(27):4288-4297:Background:Data on influenza burden in risk groups for severe influenza are important to guide targeted influenza immunization, especially in resource...
- :Duque, Jazmin ;McMorrow, Meredith L.Jan 16 2014 | BMC Public Health. 2014; 14:41.:BackgroundInfluenza viruses cause significant morbidity and mortality in Africa, particularly among high-risk groups, but influenza vaccines and antiv...
- :Kleynhans, Jackie ;Tempia, Stefano5 2022 | Emerg Infect Dis. 2022; 28(5):1055-1058:By November 2021, after the third wave of severe acute respiratory syndrome coronavirus 2 infections in South Africa, seroprevalence was 60% in a rura...
- :McMorrow, Meredith L. ;Emukule, Gideon O.Sep 17 2015 | PLoS One. 10(9).:Influenza-associated disease burden among children in tropical sub-Saharan Africa is not well established, particularly outside of the 2009 pandemic p...
- :McMorrow, Meredith L. ;Tempia, Stefano1 03 2019 | Vaccine. 37(1):25-33:Background:Due to competing health priorities, low- and middle-income countries (LMIC) may need to prioritize between different influenza vaccine risk...
- :Biggerstaff, Matthew ;Cohen, Cheryl10 31 2019 | Vaccine. 37(46):6874-6884:Background:Pregnant women and infants are at increased risk of severe disease from influenza. Antenatal influenza vaccination is safe and can reduce t...
- :Moyes, Jocelyn ;Tempia, Stefano9 2023 | Int J Infect Dis. 134:71-77:Objectives:The detection of respiratory syncytial virus (RSV) in upper airway samples does not necessarily infer causality of illness. We aimed to cal...
- :Emukule, Gideon O. ;Khagayi, SammyAug 18 2014 | PLoS One. 2014; 9(8).:BackgroundIn Kenya, detailed data on the age-specific burden of influenza and RSV are essential to inform use of limited vaccination and treatment res...
- :McMorrow, Meredith L. ;Okitolonda Wemakoy, Emile9 15 2015 | J Infect Dis. 212(6):853-860:BackgroundData on causes of death due to respiratory illness in Africa are limited.MethodsFrom January to April 2013, 28 African countries were invite...
- :McMorrow, Meredith L. ;Tempia, Stefano2 15 2019 | Clin Infect Dis. 68(5):773-780:Background.Data describing influenza– or respiratory syncytial virus (RSV)–associated hospitalized illness in children aged <5 years in Africa are...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.